PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
 
Br J Cancer. 1999 September; 81(1): 184–185.
PMCID: PMC2374364

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level

Full Text

The Full Text of this article is available as a PDF (53K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cote RJ, Skinner EC, Salem CE, Mertes SJ, Stanczyk FZ, Henderson BE, Pike MC, Ross RK. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer. 1998 Aug;78(3):413–418. [PMC free article] [PubMed]
  • Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997 Jan;157(1):199–203. [PubMed]
  • Gormley GJ, Brawley O, Thompson I. The potential application of finasteride for chemoprevention of prostate cancer. Ann N Y Acad Sci. 1995 Sep 30;768:163–169. [PubMed]
  • McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998 Feb 26;338(9):557–563. [PubMed]
  • Niesel T, Breul J, Hartung R. Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate. Urology. 1997 Jun;49(6):869–874. [PubMed]
  • Raviv G, Janssen T, Zlotta AR, Descamps F, Verhest A, Schulman CC. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol. 1996 Sep;156(3):1050–1055. [PubMed]
  • Thompson IM, Coltman CA, Jr, Crowley J. Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial. Prostate. 1997 Nov 1;33(3):217–221. [PubMed]
  • Tsukamoto S, Akaza H, Onozawa M, Shirai T, Ideyama Y. A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer. 1998 Feb 1;82(3):531–537. [PubMed]
  • Cote RJ, Skinner EC, Salem CE, Mertes SJ, Stanczyk FZ, Henderson BE, Pike MC, Ross RK. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer. 1998 Aug;78(3):413–418. [PMC free article] [PubMed]
  • McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998 Feb 26;338(9):557–563. [PubMed]
  • Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992 Apr 11;339(8798):887–889. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK